SULFADIAZINE Reviews (SULFADIAZINE)

Average Rating: 4.0 (1 Ratings)

Filter Results

Compare SULFADIAZINE with similar:

 Type: Rx Drug

  

SULFADIAZINE  (SULFADIAZINE):  This medication is used to treat and prevent a wide variety of infections. Sulfadiazine belongs to the class of drugs known as sulfa antibiotics. It works by stopping the growth of bacteria and other organisms. This antibiotic treats only certain types of infections. It will not work for viral infections (e.g., common cold, flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness. This medication should not be used in infants younger than 2 months because of the risk of serious side effects, unless treatment is for a very serious infection (congenital toxoplasmosis).   FDA Approval Date: 1994-07-29 (Sources: U.S. Centers for Medicare Services, FDA)

  

Results are sorted by Date added.

Key to Ratings: 1=LOW (I would not recommend taking this medicine.)
5=HIGH (this medicine cured me or helped me a great deal.)

Page: 1


RATING  REASONSIDE EFFECTS FOR SULFADIAZINECOMMENTSSEXAGEDURATION/
DOSAGE		DATE ADDED
 
 4  possible rheumatic fever Yeast infections, gas, nausea Some of my side effects went away after being on the medicine for a couple of months. The gas is still there but my low grade fevers and exhaustion are gone for a good part. F 35 8 months
 1/3/2008
  

SULFADIAZINE  (SULFADIAZINE):  This medication is used to treat and prevent a wide variety of infections. Sulfadiazine belongs to the class of drugs known as sulfa antibiotics. It works by stopping the growth of bacteria and other organisms. This antibiotic treats only certain types of infections. It will not work for viral infections (e.g., common cold, flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness. This medication should not be used in infants younger than 2 months because of the risk of serious side effects, unless treatment is for a very serious infection (congenital toxoplasmosis).   FDA Approval Date: 1994-07-29 (Sources: U.S. Centers for Medicare Services, FDA)

     

BACK TO TOP